Evidence map›Paper›PMID 41269451›Full record

ArticleMycotoxin research2025

Anti-fungal potential of extracts from coffee husks against two mycotoxigenic fungi.

Milena Jiménez-Gutiérrez, Rebeca Molina-Valverde, Mariana Güell-González, Andrea Irías-Mata, Patricia Esquivel, María Viñas

Abstract read
PubMed Publisher
In one paragraph

Article in Mycotoxin research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Milena Jiménez-GutiérrezCentro para Investigaciones en Granos y Semillas (CIGRAS), Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica. milena.jimenezgutierrez@ucr.ac.cr.
Rebeca Molina-ValverdeCentro para Investigaciones en Granos y Semillas (CIGRAS), Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica.
Mariana Güell-GonzálezCentro para Investigaciones en Granos y Semillas (CIGRAS), Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica.
Andrea Irías-MataCentro para Investigaciones en Granos y Semillas (CIGRAS), Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica.
Patricia EsquivelEscuela de Tecnología de Alimentos, Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica.
María ViñasCentro para Investigaciones en Granos y Semillas (CIGRAS), Universidad de Costa Rica, San José, San Pedro, 11501-2060, Costa Rica.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycotoxins are produced by some filamentous fungi that can contaminate food products and are toxic to humans and animals. The aim of this study was to evaluate the efficiency of extracts rich in bioactive compounds from one coffee industrial processing by-product (coffee husk) against two mycotoxigenic fungi and their mycotoxins. In vitro experiments showed that extracts from coffee husk had anti-fungal effect against Fusarium verticillioides and Aspergillus flavus, and the inhibition was directly proportional to the concentration of the extract. In addition, the extract had a significant anti-fungal effect over F. verticillioides in simulated stored grains (maize kernels and paddy rice). However, the reduction of aflatoxin B1 contamination was only observed in stored grains of red common beans, maize kernels and paddy rice. Bioactive compounds of coffee husk extract exhibit anti-fungal activity and demonstrated potential to reduce aflatoxin contamination in the food chain.

Indexed as

Antifungal AgentsAspergillus flavusCoffeaCoffeeFusariumMycotoxinsPlant ExtractsMicrobial Sensitivity TestsOryzaZea maysAntifungal AgentsCoffeeMycotoxinsPlant ExtractsAspergillus flavusFungal and mycotoxin inhibitionFusarium verticillioidesPhytochemicals extracts

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.